Table 1.

Phenotypic and genotypic characteristics of the MRSP isolates from Rio de Janeiro and Campo dos Goytacazes, RJ, Brazil (2010–2012)

Isolate	Year of isolation	Source	Antimicrobial resistance**	PFGE	ST (MLST)
PA36	2011	NC	ery, cli, sxt, tet	A4	ST71
PA41	2011	NC	ery, cli, sxt, tet, cip	A2	ST71
PA76	2011	NC	ery, cli, sxt, cip	A2	ST71
PA85	2011	NC	ery, cli, sxt, cip	A2	ST71
PA31	2011	NC	ery, cli, sxt, cip	A2	ST71
SA02	2011	Ear	ery, cli, gen, sxt, cip	A2	ST71
SA41	2011	Ear	ery, cli, gen, tet, cip	A2	ST71
SA62	2011	Ear	ery, cli, gen, sxt, tet, cip	A2	ST71
SA63	2011	Ear	ery, cli, gen, sxt, tet, cip	A4	ST71
SA71	2012	Ear	ery, cli, gen, sxt, tet, cip	A4	ST71
SA89	2012	Ear	ery, cli, sxt, cip	A2	ST71
SA93	2012	Ear	ery, cli, gen, sxt, tet, cip	A3	ST71
SA103	2012	Ear	ery, cli, sxt, cip	A3	ST71
SA116	2012	Ear	ery, cli, sxt, cip	A1	ST71
SD12	2010	PD	ery, cli, gen, sxt, tet, rif, cip	A1	ST71
SD71	2011	PD	sxt, tet, rif	A2	ST71
SD87	2011	PD	ery, cli, gen, sxt, cip	A4	ST71
Pa1.2*	2012	PD	ery, cli, tet	ND	ST330
Pa1.3*	2012	PD	ery, cli, tet	ND	ST330
Pa124*	2012	PD	ery, cli, sxt, cip	ND	ST71

NC, nasal cavity; PD, pyoderma; cip, ciprofloxacin (5 μg); cli, clindamycin (2 μg); ery, erythromycin (15 μg); gen, gentamicin (10 μg); rif, rifampicin (5 μg); sxt, sulfamethoxazole-trimethoprim (25 μg); tet, tetracycline (30 μg). The PFGE classification was based on the PFGE pattern of the BMBSP02 strain (a MRSP ST71 related to the European clone), which was taken as the A1 pattern; A2, three-band differences in relation to BMBSP02; A3, five-band differences; A4, six-band differences; ND, not done. ST, sequence type; and MLST, multilocus sequence typing. *Pal 2, Pal 3, and Pal 24 are MRSP isolates from Campos dos Goytacazes city. **All samples were resistant to oxacillin in the disk diffusion test